| Distinct risk factor profiles for human papillomavirus type 16–positive and human papillomavirus type 16–negative head and neck cancers ML Gillison, G D'Souza, W Westra, E Sugar, W Xiao, S Begum, R Viscidi Journal of the National Cancer Institute 100 (6), 407-420, 2008 | 2006 | 2008 |
| Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint … DF Hanley, RE Thompson, M Rosenblum, G Yenokyan, K Lane, N McBee, ... The Lancet 393 (10175), 1021-1032, 2019 | 814 | 2019 |
| Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer DT Le, E Lutz, JN Uram, EA Sugar, B Onners, S Solt, L Zheng, LA Diaz Jr, ... Journal of immunotherapy 36 (7), 382-389, 2013 | 629 | 2013 |
| Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms SD Gore, S Baylin, E Sugar, H Carraway, CB Miller, M Carducci, M Grever, ... Cancer research 66 (12), 6361-6369, 2006 | 611 | 2006 |
| Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma JM Herman, DT Chang, KA Goodman, AS Dholakia, SP Raman, ... Cancer 121 (7), 1128-1137, 2015 | 536 | 2015 |
| Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial DF Hanley, K Lane, N McBee, W Ziai, S Tuhrim, KR Lees, J Dawson, ... The Lancet 389 (10069), 603-611, 2017 | 469 | 2017 |
| A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma: a phase II trial of safety, efficacy … L Eric, CJ Yeo, KD Lillemoe, B Biedrzycki, B Kobrin, J Herman, E Sugar, ... Annals of surgery 253 (2), 328-335, 2011 | 458 | 2011 |
| Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively … JM Herman, MJ Swartz, CC Hsu, J Winter, TM Pawlik, E Sugar, ... Journal of Clinical Oncology 26 (21), 3503-3510, 2008 | 438 | 2008 |
| A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune … DT Le, DG Brockstedt, R Nir-Paz, J Hampl, S Mathur, J Nemunaitis, ... Clinical cancer research 18 (3), 858-868, 2012 | 403 | 2012 |
| Allogeneic granulocyte macrophage colony-stimulating factor–secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot … D Laheru, E Lutz, J Burke, B Biedrzycki, S Solt, B Onners, I Tartakovsky, ... Clinical Cancer Research 14 (5), 1455-1463, 2008 | 379 | 2008 |
| Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid … JH Kempen, MM Altaweel, JT Holbrook, DA Jabs, TA Louis, EA Sugar, ... Ophthalmology 118 (10), 1916-1926, 2011 | 340 | 2011 |
| Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies TE Fandy, JG Herman, P Kerns, A Jiemjit, EA Sugar, SH Choi, AS Yang, ... Blood, The Journal of the American Society of Hematology 114 (13), 2764-2773, 2009 | 315 | 2009 |
| Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer CL Hann, VC Daniel, EA Sugar, I Dobromilskaya, SC Murphy, L Cope, ... Cancer research 68 (7), 2321-2328, 2008 | 258 | 2008 |
| A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3 CL Trimble, S Peng, F Kos, P Gravitt, R Viscidi, E Sugar, D Pardoll, TC Wu Clinical Cancer Research 15 (1), 361-367, 2009 | 238 | 2009 |
| Six‐month natural history of oral versus cervical human papillomavirus infection G D'Souza, C Fakhry, EA Sugar, EC Seaberg, K Weber, HL Minkoff, ... International journal of cancer 121 (1), 143-150, 2007 | 209 | 2007 |
| Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal … JE Thorne, EA Sugar, JT Holbrook, AE Burke, MM Altaweel, AT Vitale, ... Ophthalmology 126 (2), 283-295, 2019 | 208 | 2019 |
| Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity. WJ Ho, Q Zhu, J Durham, A Popovic, S Xavier, J Leatherman, A Mohan, ... Nature cancer 2 (9), 891-903, 2021 | 185 | 2021 |
| Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy EA Sugar, DA Jabs, A Ahuja, JE Thorne, RP Danis, CL Meinert, ... American journal of ophthalmology 153 (6), 1016-1024. e5, 2012 | 164 | 2012 |
| Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults DC Beachler, EA Sugar, JB Margolick, KM Weber, HD Strickler, DJ Wiley, ... American journal of epidemiology 181 (1), 40-53, 2015 | 160 | 2015 |
| Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma A De Jesus-Acosta, EA Sugar, PJ O’Dwyer, RK Ramanathan, ... British journal of cancer 122 (4), 498-505, 2020 | 143 | 2020 |
